Kim Clark-Langone

Title: Kim Clark-Langone: Innovator in Cancer Genomics

Introduction

Kim Clark-Langone is a prominent inventor based in Sunnyvale, California. She has made significant contributions to the field of cancer genomics, particularly in the development of algorithms that aid in the prognosis and treatment of colorectal cancer. Her innovative work has the potential to improve patient outcomes through personalized medicine.

Latest Patents

Kim holds a patent for a gene expression profile algorithm and test that assesses the likelihood of recurrence of colorectal cancer and the response to chemotherapy. This patent involves algorithm-based molecular assays that measure the expression levels of prognostic and predictive genes from biological samples obtained from cancer patients. The analysis of these expression levels provides crucial information regarding the likelihood of cancer recurrence and the potential benefits of chemotherapy for patients.

Career Highlights

Kim Clark-Langone has had a distinguished career in the biotechnology sector. She is currently associated with Genomic Health, Inc., where she continues to advance research in cancer diagnostics. Her work focuses on developing methods for analyzing gene expression values and identifying gene expression-tumor region ratios, which are essential for understanding cancer biology.

Collaborations

Some of her notable coworkers include Steven Shak and Drew Watson, who have also contributed to the advancements in cancer genomics. Their collaborative efforts have led to significant innovations in the field.

Conclusion

Kim Clark-Langone's contributions to cancer genomics through her patented algorithms exemplify the impact of innovation in healthcare. Her work not only enhances our understanding of cancer but also paves the way for more effective treatment strategies for patients.